Cell-Based Therapies for Stroke: Are We There Yet?

Stroke is the second leading cause of death and physical disability, with a global lifetime incidence rate of 1 in 6. Currently, the only FDA approved treatment for ischemic stroke is the administration of tissue plasminogen activator (tPA). Stem cell clinical trials for stroke have been underway fo...

Full description

Saved in:
Bibliographic Details
Published in:Front Neurol
Main Authors: Krause, Mirja, Phan, Thanh G., Ma, Henry, Sobey, Christopher G., Lim, Rebecca
Format: Artigo
Language:Inglês
Published: Frontiers Media S.A. 2019
Subjects:
Neurology
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6603096/
https://ncbi.nlm.nih.gov/pubmed/31293500
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2019.00656
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items